rhodamine 123 has been researched along with pirarubicin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartolucci, G; Coronnello, M; Dei, S; Floriddia, E; Manetti, D; Romanelli, MN; Salerno, M; Santo Domingo Porqueras, D; Teodori, E | 1 |
1 other study(ies) available for rhodamine 123 and pirarubicin
Article | Year |
---|---|
N-alkanol-N-cyclohexanol amine aryl esters: Multidrug resistance (MDR) reversing agents with high potency and efficacy.
Topics: Amines; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cyclohexanols; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Stability; Esters; Humans; K562 Cells; Rhodamine 123 | 2017 |